Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-22

FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for the analgesic combination butalbital/acetaminophen/caffeine from Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital; acetaminophen; caffeine)

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE)